Methyl 3-fluoro-5-methylpyrazolo[1,5-a]pyrimidine-7-carboxylate | 916211-88-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡唑并嘧啶类
• 英文名称: Methyl 3-fluoro-5-methylpyrazolo[1,5-a]pyrimidine-7-carboxylate
• CAS: 916211-88-6
• 化学式: C₉H₈FN₃O₂
• 分子量: 209.18
• InChiKey: CNFGASORFJJXJR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  56.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  5-甲基吡唑并[1,5-a]嘧啶-7-羧酸甲酯 在 Selectfluor 作用下， 以 溶剂黄146 、 乙腈 为溶剂， 反应 7.0h， 以27%的产率得到Methyl 3-fluoro-5-methylpyrazolo[1,5-a]pyrimidine-7-carboxylate
  参考文献：
  名称：

  WO2008/63671

  摘要：

  公开号：

文献信息

• Heterobicyclic metalloprotease inhibitors
  申请人：Nolte Bert

  公开号：US20080176870A1

  公开（公告）日：2008-07-24

  The present invention relates generally to heterobicyclic containing pharmaceutical agents, and in particular, to heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic metalloprotease inhibiting compounds that exhibit an increased potency in relation to currently known metalloprotease inhibitors.

  本发明涉及含有杂环的药物，特别是含有杂环的金属蛋白酶抑制剂化合物。更具体地说，本发明提供了一类新的杂环金属蛋白酶抑制剂化合物，其相对于当前已知的金属蛋白酶抑制剂表现出更高的效力。
• Heterobicyclic Metalloprotease Inhibitors
  申请人：STEENECK Christoph

  公开号：US20090312312A1

  公开（公告）日：2009-12-17

  The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
• HETEROBICYCLIC METALLOPROTEASE INHIBITORS
  申请人：Steeneck Christoph

  公开号：US20120015920A1

  公开（公告）日：2012-01-19

  The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-13 inhibiting and MMP-3 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP-13 and MMP-3 inhibitors.
• US7795245B2
  申请人：——

  公开号：US7795245B2

  公开（公告）日：2010-09-14
• US8835441B2
  申请人：——

  公开号：US8835441B2

  公开（公告）日：2014-09-16